Even though the disease pathogenesis is unclear, multiple fibroblast activation factors, such as transforming growth factor beta (TGF-β) and platelet-derived growth factor (PDGF), have been implicated in both SSc and ILD1,6,17–20. Here, TGFB1 is linked to systemic sclerosis.